WP-2011

Open label study of WP-2011 multifocal intraocular lens in patients with aphakic eye patients after cataract surgery

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2032210035

Enrollment

100

Registered

2021-04-12

Start date

2021-07-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract

Interventions

Implantation of intraocular after cataract surgery

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who scheduled to remove the crystalline lens by phacoemulsification and aspiration

Exclusion criteria

Exclusion criteria: Patients with indication for secondary lens implantation. Patients with uncontrolled glaucoma. Pregnant women, lactating women or women who desire to be pregnant. Patients who are judged inappropriate to participate in the study by principal investigator or sub-investigator.

Design outcomes

Primary

Measure	Time frame
Visual acuity after lens implantation. Incidence of adverse events and defects.	—

Contacts

Public ContactHideyuki Kami-ie

Wakamoto Pharmaceutical Co., Ltd.

hideyuki.kamiie@wakamoto-pharm.co.jp+81-3-3279-0370

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026